Clinical Trial

Magnetic Stimulation of Diaphragm in Chronic Obstructive Pulmonary Disease

Study acronym: COPD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated August 4, 2025 completion). Its status may not reflect the trial's current state.
Summary
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation and respiratory symptoms due to airway and/or alveolar deterioration caused by severe exposure to harmful particles or gases and host factors. Exercise intolerance and decreased functional capacity develop as a result of the disorders that occur in COPD. The aim of this study is to evaluate the effectiveness of repetitive peripheral magnetic stimulation (rPMS), an easy and inexpensive method to increase diaphragm strength as an adjunct to the pulmonary rehabilitation (PR) program applied in COPD, and to investigate the effect of this method on exercise capacity, diaphragm muscle thickness and symptoms.
Trial Details
NCT Number NCT06714721
Lead Sponsor Ankara University
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 66 participants
Start Date 2023-08-23
Primary Completion 2025-08-04 (estimated)
Study Completion 2025-12-04 (estimated)
Updated on ClinicalTrials.gov 2024-12-04